par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • June 30th, 2016 • Vitae Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledJune 30th, 2016 Company Industry JurisdictionVitae Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: